Chemistry Rx Compounding and Specialty Pharmacy
Jonathan Mordis, Pharm D, is an experienced professional who has held various key roles in the pharmaceutical and healthcare industry. Jonathan currently serves as the Chief Executive Officer at Chemistry Rx Compounding and Specialty Pharmacy. With a background in pharmacy management, consulting, and business development, Jonathan has a track record of successfully launching and overseeing various healthcare ventures and compounding pharmacies. Their expertise extends to financial consulting, clinical services management, and surgical account executive roles. Jonathan is known for their leadership in national launches and business development initiatives within the healthcare sector.
This person is not in any teams
Chemistry Rx Compounding and Specialty Pharmacy
Chemistry Rx is an ACHC & URAC accredited compounding and specialty pharmacy located in Folcroft, PA. Licensed in all 50 states, our mission is to provide exceptional service to our patients, providers and DTC telemedicine partners. The unique aspect about our services is our clinically-centered approach, assessing the patient's primary problem and recommending novel treatment options where compound therapies could play a significant role. Through extensive networking and research, we provide evidence based recommendations for complex cases where minimal drug therapies currently exist. Our multidisciplinary team consisting of pharmacists and nurses, have experience managing patients requiring compounded therapies for various diseases and conditions, acute and chronic, and in both adult and pediatric populations. "Overall, our pharmacists and nurses provide exceptional clinical services and ensure patient satisfaction. We are ready to take on the most challenging patient cases. Personalizing medicine, one compound at a time."